FENNEC PHARMACEUTICALS INC.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.9M | — | — | — | — | — | — | — |
| Operating Income | $-4.6M | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-7.8M | $-3.0M | $-13.6M | $-13.4M | $-16.4M | $-13.9M | $-6.9M | $-17.8M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.49 | — | — | — | — | — | — | — |
| EPS (Diluted) | $-0.49 | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 16.0M | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 16.0M | — | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |